Alerts will be sent to your verified email
Verify EmailBIOFILCHEM
Biofil Chem & Pharma
|
Achyut Healthcare
|
Makers Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
5.42 % | 2.96 % | -2.27 % |
5yr average Equity Multiplier
|
2.09 | 1.26 | 2.42 |
5yr Average Asset Turnover Ratio
|
0.96 | 0.52 | 0.68 |
5yr Avg Net Profit Margin
|
2.86 % | 5.4 % | -1.81 % |
Price to Book
|
4.24 | 0.0 | 1.26 |
P/E
|
128.58 | 150.2 | 14.17 |
5yr Avg Cash Conversion Cycle
|
65.55 Days | 16.69 Days | 81.6 Days |
Inventory Days
|
25.38 Days | 35.91 Days | 108.24 Days |
Days Receivable
|
244.02 Days | 20.4 Days | 69.51 Days |
Days Payable
|
179.27 Days | 81.77 Days | 109.89 Days |
5yr Average Interest Coverage Ratio
|
21.93 | 144.78 | 3.06 |
5yr Avg ROCE
|
7.69 % | 4.18 % | 4.88 % |
5yr Avg Operating Profit Margin
|
4.5 % | -0.85 % | 7.75 % |
5 yr average Debt to Equity
|
0.04 | 0.0 | 0.25 |
5yr CAGR Net Profit
|
-10.11 % | 124.48 % | 80.14 % |
5yr Average Return on Assets
|
2.72 % | 2.24 % | -0.95 % |
Shareholdings
|
|||
Promoter Holding
|
46.82 % | 46.11 % | 61.27 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -20.07 % | 2.9 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Biofil Chem & Pharma
|
Achyut Healthcare
|
Makers Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|